Profile data is unavailable for this security.
About the company
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.
- Revenue in HKD (TTM)12.44m
- Net income in HKD-189.22m
- Incorporated2018
- Employees136.00
- LocationKintor Pharmaceutical LtdNo. 20 Songbei RoadSuzhou Industrial ParkSUZHOU 215123ChinaCHN
- Phone+86 51 262639909
- Websitehttps://www.kintor.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sirnaomics Ltd | 13.90m | -109.55m | 768.78m | 52.00 | -- | -- | -- | 55.32 | -1.33 | -1.33 | 0.161 | -0.3804 | 0.0637 | -- | -- | 201,403.60 | -36.30 | -80.21 | -216.85 | -100.49 | 67.44 | -- | -570.30 | -27,838.86 | -- | -8.20 | -- | -- | -- | -- | 34.70 | -- | -38.10 | -- |
| JW (Cayman) Therapeutics Co Ltd | 201.32m | -699.51m | 941.23m | 292.00 | -- | 0.9141 | -- | 4.68 | -1.69 | -1.69 | 0.4852 | 2.47 | 0.1046 | 1.34 | 9.59 | 716,429.40 | -36.34 | -35.14 | -47.41 | -39.06 | 55.52 | -- | -347.47 | -898.77 | 1.45 | -1,808.42 | 0.2907 | -- | -8.99 | -- | 23.10 | -- | -32.98 | -- |
| Sunho Biologics Inc | 0.00 | -92.97m | 1.00bn | 128.00 | -- | 1.84 | -- | -- | -0.616 | -0.616 | 0.00 | 3.48 | 0.00 | -- | -- | 0.00 | -14.33 | -- | -15.84 | -- | -- | -- | -- | -- | 6.57 | -- | 0.1242 | -- | -- | -- | 39.74 | -- | -- | -- |
| B&K Corp Ltd | 295.61k | -206.83m | 1.09bn | 100.00 | -- | 11.43 | -- | 3,701.60 | -1.76 | -1.76 | 0.0025 | 0.8138 | -- | -- | -- | -- | -- | -- | -- | -- | 92.34 | -- | -69,968.59 | -- | -- | -- | 0.0371 | -- | -44.70 | -- | -101.78 | -- | -- | -- |
| Brii Biosciences Ltd | 0.00 | -425.51m | 1.13bn | 96.00 | -- | 0.3986 | -- | -- | -0.5846 | -0.5846 | 0.00 | 3.91 | 0.00 | -- | -- | 0.00 | -14.05 | -49.92 | -14.09 | -54.57 | -- | -- | -- | -12,750.27 | -- | -- | 0.003 | -- | -100.00 | -- | -190.66 | -- | -33.13 | -- |
| Kintor Pharmaceutical Ltd | 12.44m | -189.22m | 1.39bn | 136.00 | -- | 5.10 | -- | 111.83 | -0.4375 | -0.4375 | 0.0288 | 0.5467 | 0.0194 | 10.66 | 1.06 | 74,049.78 | -29.53 | -47.72 | -44.54 | -55.96 | -55.12 | -36.16 | -1,521.00 | -8,974.73 | 0.4222 | -33.76 | 0.2881 | -- | -- | -- | 85.36 | -- | -53.11 | -- |
| Wuhan YZY Biopharma Co Ltd | 164.23m | -88.38m | 1.40bn | 106.00 | -- | -- | -- | 8.55 | -0.4559 | -0.4559 | 0.8472 | -0.1604 | 0.5805 | 11.54 | 13.96 | 1,453,323.00 | -31.24 | -- | -133.35 | -- | 63.96 | -- | -53.82 | -- | 0.9019 | -24.38 | 1.21 | -- | -- | -- | 49.09 | -- | -- | -- |
| HighTide Therapeutics Inc | 0.00 | -329.76m | 1.49bn | 57.00 | -- | 3.75 | -- | -- | -0.7294 | -0.7294 | 0.00 | 0.6942 | 0.00 | -- | -- | 0.00 | -49.50 | -- | -63.55 | -- | -- | -- | -- | -- | -- | -- | 0.2129 | -- | -- | -- | 59.35 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -253.13m | 1.60bn | 173.00 | -- | -- | -- | -- | -0.4523 | -0.4523 | 0.00 | -0.2882 | 0.00 | -- | -- | 0.00 | -37.04 | -36.20 | -186.73 | -45.67 | -- | -- | -- | -- | 0.0712 | -6.63 | 1.48 | -- | -- | -- | 44.18 | -- | 5.95 | -- |
| Cloudbreak Pharma Inc | 78.16m | -326.97m | 1.91bn | 60.00 | -- | -- | -- | 24.47 | -0.3898 | -0.3898 | 0.0932 | -3.08 | -- | -- | -- | 1,532,549.00 | -- | -- | -- | -- | -- | -- | -418.33 | -- | -- | -- | 19.44 | -- | -- | -- | 23.40 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 126.96m | -342.81m | 1.98bn | 195.00 | -- | 3.08 | -- | 15.57 | -0.8715 | -0.8715 | 0.3225 | 1.49 | 0.148 | -- | 3,865.48 | 813,859.90 | -40.09 | -- | -51.56 | -- | -- | -- | -270.79 | -- | -- | -- | 0.2236 | -- | 19,109.59 | -- | 16.76 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Kintor Pharmaceutical Ltd's reporting currency: Hong Kong Dollar HKD
0.31%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 1.19m | 0.24% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 372.00k | 0.08% |
| DFA Australia Ltd.as of 30 Nov 2025 | 1.10k | 0.00% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
